Research across Pelvic organ prolapse
Related studies from across the Pelvic organ prolapse family.
8 trials tracked for uterine prolapse: 5 in phase 3 or 4 and 1 with published results. The most-cited published study has 23 citations.
Showing the 8 most-cited and recently-updated of 8 trials. Browse the full registry →
Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.
Surgical interventions for uterine prolapse show varying results regarding anatomical success and complication rates. Synthetic polypropylene mesh was evaluated for anterior prolapse, with a reported objective treatment success rate of 10% to 12% at one year 3. Grafted anterior prolapse repair demonstrated significantly lower rates of recurrent Stage II or greater anterior vaginal prolapse (11% vs. 24%, p=0.005) compared to other methods, while showing no significant difference in operative time (p=0.5) but a statistically significant difference in vaginal mesh exposure (p<0.05) 5.
Pharmacological and supportive interventions provide different clinical outcomes. Conjugated Estrogens Cream was evaluated in a Phase 4 study 1. Water-based vaginal lubricants were associated with voiding efficiency metrics of 94.6% and 95.9% 2. In surgical settings involving Rocuronium, peak airway pressures showed significant variation (p=0.01), while abdominal insufflation pressure and surgical rating scales did not show statistically significant differences (p=0.28, p=0.63 respectively) 4.
AI synthesis of 8 cited trials, updated Jun 29, 2026. Informational only — not medical advice; trial data sourced from ClinicalTrials.gov. How we use AI.
Related studies from across the Pelvic organ prolapse family.